33 States to Get $62 Million in Zyprexa Case Settlement
Wednesday, October 8, 2008 - 11:00
in Mathematics & Economics
Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa to patients who did not have schizophrenia or bipolar disorder.